These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

526 related articles for article (PubMed ID: 36941591)

  • 1. Risk of SARS-CoV-2 infection, severe COVID-19 illness and COVID-19 mortality in people with pre-existing mental disorders: an umbrella review.
    Bertolini F; Witteveen AB; Young S; Cuijpers P; Ayuso-Mateos JL; Barbui C; Cabello M; Cadorin C; Downes N; Franzoi D; Gasior ME; Gray B; John A; Melchior M; van Ommeren M; Palantza C; Purgato M; Van der Waerden J; Wang S; Sijbrandij M
    BMC Psychiatry; 2023 Mar; 23(1):181. PubMed ID: 36941591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of COVID-19 and other pandemics and epidemics on people with pre-existing mental disorders: a systematic review protocol and suggestions for clinical care.
    Sergeant A; van Reekum EA; Sanger N; Dufort A; Rosic T; Sanger S; Lubert S; Mbuagbaw L; Thabane L; Samaan Z
    BMJ Open; 2020 Sep; 10(9):e040229. PubMed ID: 32873685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kidney health in the COVID-19 pandemic: An umbrella review of meta-analyses and systematic reviews.
    Yang L; Li J; Wei W; Yi C; Pu Y; Zhang L; Cui T; Ma L; Zhang J; Koyner J; Zhao Y; Fu P
    Front Public Health; 2022; 10():963667. PubMed ID: 36172213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mental burden and its risk and protective factors during the early phase of the SARS-CoV-2 pandemic: systematic review and meta-analyses.
    Kunzler AM; Röthke N; Günthner L; Stoffers-Winterling J; Tüscher O; Coenen M; Rehfuess E; Schwarzer G; Binder H; Schmucker C; Meerpohl JJ; Lieb K
    Global Health; 2021 Mar; 17(1):34. PubMed ID: 33781283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interventions to support the resilience and mental health of frontline health and social care professionals during and after a disease outbreak, epidemic or pandemic: a mixed methods systematic review.
    Pollock A; Campbell P; Cheyne J; Cowie J; Davis B; McCallum J; McGill K; Elders A; Hagen S; McClurg D; Torrens C; Maxwell M
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD013779. PubMed ID: 33150970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mental disorders and risk of COVID-19-related mortality, hospitalisation, and intensive care unit admission: a systematic review and meta-analysis.
    Vai B; Mazza MG; Delli Colli C; Foiselle M; Allen B; Benedetti F; Borsini A; Casanova Dias M; Tamouza R; Leboyer M; Benros ME; Branchi I; Fusar-Poli P; De Picker LJ
    Lancet Psychiatry; 2021 Sep; 8(9):797-812. PubMed ID: 34274033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of the COVID-19 pandemic on the mental health of hospital staff: An umbrella review of 44 meta-analyses.
    Dragioti E; Tsartsalis D; Mentis M; Mantzoukas S; Gouva M
    Int J Nurs Stud; 2022 Jul; 131():104272. PubMed ID: 35576637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 and common mental health symptoms in the early phase of the pandemic: An umbrella review of the evidence.
    Witteveen AB; Young SY; Cuijpers P; Ayuso-Mateos JL; Barbui C; Bertolini F; Cabello M; Cadorin C; Downes N; Franzoi D; Gasior M; Gray B; Melchior M; van Ommeren M; Palantza C; Purgato M; van der Waerden J; Wang S; Sijbrandij M
    PLoS Med; 2023 Apr; 20(4):e1004206. PubMed ID: 37098048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mental and neurological disorders and risk of COVID-19 susceptibility, illness severity and mortality: A systematic review, meta-analysis and call for action.
    Liu L; Ni SY; Yan W; Lu QD; Zhao YM; Xu YY; Mei H; Shi L; Yuan K; Han Y; Deng JH; Sun YK; Meng SQ; Jiang ZD; Zeng N; Que JY; Zheng YB; Yang BN; Gong YM; Ravindran AV; Kosten T; Wing YK; Tang XD; Yuan JL; Wu P; Shi J; Bao YP; Lu L
    EClinicalMedicine; 2021 Oct; 40():101111. PubMed ID: 34514362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Social Distance in COVID-19: Drawing the line between protective behavior and stigma manifestation.
    Economou M
    Psychiatriki; 2021 Sep; 32(3):183-186. PubMed ID: 34390552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a rapid review.
    Valk SJ; Piechotta V; Chai KL; Doree C; Monsef I; Wood EM; Lamikanra A; Kimber C; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N
    Cochrane Database Syst Rev; 2020 May; 5(5):CD013600. PubMed ID: 32406927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the COVID-19 pandemic on people experiencing incarceration: a systematic review.
    Williams DB; Spinks B; Williams D; Lewis R; Bull F; Edwards A
    BMJ Open; 2024 Apr; 14(4):e076451. PubMed ID: 38582532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurological, Psychiatric, and Psychological Implications of the COVID-19 Pandemic: Protocol for a Large-Scale Umbrella Review of Observational Studies.
    Yeh TC; Liang CS; Tsai CK; Solmi M; Lafer B; Tseng PT; Hsu CW; Lin PY; Firth J; Stubbs B; Hassan L; Fornaro M; Vieta E; Thompson T; Shin J; Carvalho AF
    Int J Environ Res Public Health; 2022 Feb; 19(3):. PubMed ID: 35162704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 susceptibility and COVID-19 illness course and outcome in people with pre-existing neurodegenerative disorders: systematic review with frequentist and Bayesian meta-analyses.
    Smadi M; Kaburis M; Schnapper Y; Reina G; Molero P; Molendijk ML
    Br J Psychiatry; 2023 Aug; 223(2):348-361. PubMed ID: 37183681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association Between the Use of Psychotropic Medications and the Risk of COVID-19 Infection Among Long-term Inpatients With Serious Mental Illness in a New York State-wide Psychiatric Hospital System.
    Nemani K; Williams SZ; Olfson M; Leckman-Westin E; Finnerty M; Kammer J; Smith TE; Silverman DJ; Lindenmayer JP; Capichioni G; Clelland J; Goff DC
    JAMA Netw Open; 2022 May; 5(5):e2210743. PubMed ID: 35522282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physical interventions to interrupt or reduce the spread of respiratory viruses.
    Jefferson T; Del Mar CB; Dooley L; Ferroni E; Al-Ansary LA; Bawazeer GA; van Driel ML; Jones MA; Thorning S; Beller EM; Clark J; Hoffmann TC; Glasziou PP; Conly JM
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD006207. PubMed ID: 33215698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Joint European policy on the COVID-19 risks for people with mental disorders: An umbrella review and evidence- and consensus-based recommendations for mental and public health.
    Vai B; Mazza MG; Marisa CD; Beezhold J; Kärkkäinen H; Saunders J; Samochowiec J; Benedetti F; Leboyer M; Fusar-Poli P; De Picker L
    Eur Psychiatry; 2022 Aug; 65(1):e47. PubMed ID: 35971656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Letter to the Editor: THE IMPACT OF THE COVID-19 PANDEMIC ON SCHIZOPHRENIA PATIENTS.
    Hoşgelen EI; Alptekin K
    Turk Psikiyatri Derg; 2021; 32(3):219-221. PubMed ID: 34750798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Letter to the Editor: THE IMPACT OF THE COVID-19 PANDEMIC ON SCHIZOPHRENIA PATIENTS.
    Hoşgelen EI; Alptekin K
    Turk Psikiyatri Derg; 2021; 32(3):219-221. PubMed ID: 34637131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.